APA (7th ed.) Citation

A, S., W, S., MG, A., D, F., H, E., Z, C., . . . DW, B. (2022). Key use cases for artificial intelligence to reduce the frequency of adverse drug events: A scoping review. The Lancet. Digital health, 4(2), e137. https://doi.org/10.1016/S2589-7500(21)00229-6

Chicago Style (17th ed.) Citation

A, Syrowatka, et al. "Key Use Cases for Artificial Intelligence to Reduce the Frequency of Adverse Drug Events: A Scoping Review." The Lancet. Digital Health 4, no. 2 (2022): e137. https://doi.org/10.1016/S2589-7500(21)00229-6.

MLA (9th ed.) Citation

A, Syrowatka, et al. "Key Use Cases for Artificial Intelligence to Reduce the Frequency of Adverse Drug Events: A Scoping Review." The Lancet. Digital Health, vol. 4, no. 2, 2022, p. e137, https://doi.org/10.1016/S2589-7500(21)00229-6.